Impact of T Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen-Reference-Cited by-同舟云学术

Impact of T Cell Chimerism on Clinical Outcome in 117 Patients Who Underwent Allogeneic Stem Cell Transplantation with a Busulfan-Containing Reduced-Intensity Conditioning Regimen

Published:2008-10 Issue:10 Volume:14 Page:1148-1155
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Saito Bungo,Fukuda Takahiro,Yokoyama Hiroki,Kurosawa Saiko,Takahashi Toshihiro,Fuji Shigeo,Takahashi Noriko,Tajima Kinuko,Kim Sung-Won,Mori Shin-ichiro,Tanosaki Ryuji,Takaue Yoichi,Heike Yuji

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses;Childs;Blood,1999

2. Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

3. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases;Slavin;Blood,1998

4. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning;Baron;Blood,2004

5. In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation;Kottaridis;Blood,2000

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospects and Potential for Chimerism Analysis after Allogeneic Hematopoietic Stem Cell Transplantation;Cells;2024-06-06

2. Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS;Blood Advances;2023-07-17

3. Immune tolerance induced by hematopoietic stem cell infusion after HLA identical sibling kidney transplantation;Frontiers in Immunology;2022-08-23

4. Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation: Correlation with acute GVHD grades III–IV and no impact on relapse and overall survival;European Journal of Haematology;2022-04-27

5. Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia;Bone Marrow Transplantation;2022-02-24